Status:
COMPLETED
The Research of Metabolomics on COPD
Lead Sponsor:
Guangzhou Institute of Respiratory Disease
Collaborating Sponsors:
The Fifth Affiliated Hospital of Zunyi Medical College
Conditions:
Metabolomics
Omega 6
Eligibility:
All Genders
40-80 years
Brief Summary
Targeted metabolomics research was conducted on patients with chronic obstructive pulmonary disease (COPD). The correlation analyst between inflammation-related metabolites and lung function was analy...
Detailed Description
Based on the global initiative for chronic obstructive pulmonary disease, the 80 confirmed stable COPD patients with mild-to-moderate were involved, 80 COPD patients with severe and very severe, and a...
Eligibility Criteria
Inclusion
- COPD diagnosis
- The age ranges from 40 to 80
- No other pulmonary diseases
- No immune-related diseases
Exclusion
- Not consistent with COPD diagnosis
- Age is out of range
- Interstitial lung disease, asthma and other lung diseases
- Immune system diseases
- Lost to follow-up
Key Trial Info
Start Date :
October 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 5 2019
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04042519
Start Date
October 1 2016
End Date
July 5 2019
Last Update
August 2 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.